GelRx™-based Prescription Pharmaceutical
Undisclosed
Pre-clinical (inferred)Active
Key Facts
About Engineered BioPharmaceuticals
Engineered BioPharmaceuticals, founded in 2014, is a private, pre-revenue biotech company developing advanced drug delivery systems aimed at reducing healthcare costs through improved patient compliance. Its core innovation is the GelRx™ oral delivery technology, designed to fit seamlessly into a patient's lifestyle. The company leverages over 14 years of collective expertise in pharmaceutical engineering and is led by a seasoned executive team with strong backgrounds in medical devices and pharmaceutical development. Its initial focus is on advancing its first prescription pharmaceutical product based on this platform.
View full company profileOther Undisclosed Drugs
| Drug | Company | Phase |
|---|---|---|
| Preclinical ISAC 1 | Bolt Biotherapeutics | Preclinical |
| Preclinical ISAC 2 | Bolt Biotherapeutics | Preclinical |
| ART12.11 | Artelo Biosciences | Preclinical |
| Novel Vaccines | MSD | Development |
| SLS-009 | Seelos Therapeutics | Discovery |
| Technosphere Platform (New Formulations) | MannKind | Discovery/Preclinical |
| Measovir®-based Prophylactic Vaccine (with Unither) | Oncovita | Research/Pre-clinical |
| Internal sdAb Discovery Program | NanoTag Biotechnologies | Discovery |
| NB-701 | Nerai Biosciences | Discovery |
| Undisclosed Therapeutic Program(s) | Bright Cell | Clinical Trial (Phase unspecified) |
| Biosimilars Pipeline | Intelligent Therapeutics | Pre-clinical/Development |
| Proprietary Therapeutic Pipeline | Excelsior Sciences | Discovery |